# Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer

> **NCT05679856** · NA · UNKNOWN · sponsor: **National Cancer Institute, Egypt** · enrollment: 50 (estimated)

## Conditions studied

- Larynx Cancer Stage I
- Glottic Carcinoma

## Interventions

- **RADIATION:** Hypofractionated single vocal cord irradiation
- **RADIATION:** Whole laryngeal radiotherapy

## Key facts

- **NCT ID:** NCT05679856
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05679856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05679856, "Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05679856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*